Eligibility, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Testing Uptake- The Number of Valid Responses That Confirmed COVID-19 Testing Was Completed by HouseholdsPrimary· Monthly (up to 16-months post-baseline)
The study team will examine whether students and/or members of their household tested by analyzing the number of valid responses that confirmed COVID-19 testing was completed by households
Group
Value
95% CI
Usual Care
.1603
± .3669
Text Messaging (TM)
.2552
± .4361
Text Messaging Plus Health Navigation
.2484
± .4322
Missed School DaysSecondary· Monthly (up to 16-months post-baseline)
The study team will examine the number of missed school days enrolled students missed due to COVID-19 related reasons (e.g., exposure, testing).
Group
Value
95% CI
Usual Care
.25
± 1.11
Text Messaging (TM)
.37
± 1.27
Text Messaging Plus Health Navigation
.38
± 1.17
Sponsor's own description
This project will address key testing challenges in Utah schools by building on collaborations with public school districts, private schools, charter schools and with Utah Department of Health on coronavirus disease (COVID-19) testing and existing infrastructure. The study team will work closely with schools and the Utah public health system to implement and test a shovel-ready and scalable health information technology approach that delivers automated text messages (TM) to students' parents around COVID-19 testing. In addition, some parents will receive a health navigator (HN) follow-up to ensure that tests are completed. Families will be offered the recently FDA-approved in-home serial testing approach if accessing in-person testing is a challenge. While this project is focused on COVID-19 testing, in the case that the COVID-19 vaccination becomes more relevant or is the priority of the school, the study team is able to tailor the intervention to focus on the vaccine as well. The outcomes in this study utilized parent/student reported data. Staff data were also collected but will not be reflected in primary outcome analyses.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
NCT02957513 — The Management of Diabetes in Everyday Life Program
· NA
· unknown
Other recruiting trials for COVID-19
Currently open trials in the same condition.
NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults
· Phase 1
· active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
· Phase 3
· active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
· Phase 1
· recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults
· Phase 2
· recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A
· Phase 3
· active not recruiting
Other University of Utah trials
Trials by the same sponsor.
NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies
· NA
· not yet recruiting
NCT07225426 — Personalizing Financial Incentives
· NA
· recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness
· NA
· recruiting
NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers
· NA
· not yet recruiting
NCT04208984 — Diversion Device With Breath Control
· withdrawn
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Utah
Last refreshed: 31 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05112900.